Understanding Intraductal Breast Papillomatosis
At a Glance
Breast papillomatosis is a benign condition in which multiple growths form inside the milk ducts. Atypia, meaning unusual cells, or a biopsy that does not explain the imaging may require more evaluation. When results match, monitoring may be possible; otherwise, surgery may be considered.
Receiving a diagnosis of intraductal breast papillomatosis can be overwhelming, especially when the name sounds so similar to other, more serious conditions. It is common to feel a rush of anxiety when you hear terms like “tumor” or “mass,” but it is important to know that this is a benign (non-cancerous) condition [1][2].
At its simplest, papillomatosis means you have multiple small, wart-like growths developing inside the milk ducts of your breast. While they require careful evaluation to ensure no other issues are present, they are not breast cancer [3][4].
What is Papillomatosis?
To understand papillomatosis, it helps to look at the anatomy of the breast. Your breast is made of lobes and ducts that carry milk to the nipple. Sometimes, the cells lining these ducts grow more than they should, forming a small mass called a papilloma.
When only one of these growths is found, usually in a large duct near the nipple, it is called a solitary intraductal papilloma [1]. When multiple growths are found, often deeper in the breast tissue (the “peripheral” area), the condition is called multiple intraductal papillomas or papillomatosis [1][5].
The Biology of a Papilloma
Under a microscope, a papilloma has a very specific structure. Doctors look for fibrovascular cores, which are finger-like projections made of connective tissue and blood vessels [6]. These “fingers” are covered by two layers of cells:
- Luminal epithelial cells: The cells that line the inner surface of the duct.
- Myoepithelial cells: A second, outer (basal) layer of cells that help provide structure [2].
The presence of both cell layers is a hallmark of a benign growth. In many types of invasive breast cancer, that second layer of myoepithelial cells is missing or broken, which helps pathologists tell the difference between a harmless papilloma and invasion [7][8].
Papillomatosis vs. Solitary Papilloma
While both are benign, they often behave differently and are found in different ways:
| Feature | Solitary Intraductal Papilloma | Multiple Papillomas / Papillomatosis |
|---|---|---|
| Number | One single growth [1]. | Multiple growths [1]. |
| Location | Usually central (near the nipple) [5]. | Usually peripheral (deeper in the breast) [5]. |
| Common Symptoms | Clear or bloody nipple discharge [3]. | Often no symptoms; found on screening [1]. |
| Detection | Often felt as a lump or found due to discharge [3]. | Often seen as tiny calcium deposits (microcalcifications) on a mammogram [9]. |
Understanding “Atypia”
The most important word to look for in your pathology report is atypia.
- Without atypia: This means the cells in the papilloma look normal and healthy, even though they are growing in a mass [10].
- With atypia: This means some cells have begun to look slightly unusual. It is still not cancer, but it is considered a “high-risk” lesion because it may be more likely to be found near a cancer or to develop into one later [11][12]. If the area of unusual cells is small, it is called atypical ductal hyperplasia (ADH).
- Ductal Carcinoma in Situ (DCIS): If the unusual cells meet specific criteria, the diagnosis is DCIS. Unlike ADH, DCIS is a non-invasive breast cancer (the cells are malignant but still trapped inside the milk duct). A DCIS diagnosis requires a distinct specialist treatment discussion [2][13].
Common Misunderstandings and Fears
It is natural to worry when you are told there are “multiple masses” or calcifications in your breast. Here are a few things to keep in mind to help ground your perspective:
- “Multiple” alters risk assessment: While the papillomas themselves are not cancer, multiple papillomas (papillomatosis) or peripheral lesions can make sampling harder and may slightly increase future breast-cancer risk compared to a solitary lesion. The distinction means they require individualized assessment, not that they are automatically identical to a single low-risk growth [1].
- Symptoms require evaluation: A bloody nipple discharge or a palpable lump are symptoms compatible with a papilloma, but they are not specific. Spontaneous bloody discharge and a new mass can also occur with malignancy, which is why these symptoms require appropriate imaging and tissue correlation rather than assigning a benign cause in advance [3][14].
- The “Upgrade” concern: You might hear your doctor talk about the risk of an “upgrade.” This refers to the possibility that a surgical biopsy might find something more serious that the needle biopsy missed. For a benign, strictly defined, completely “concordant” solitary papilloma without atypia, this risk is estimated between 1.4% and 1.7% in some studies [10][15]. For multiple papillomatosis, especially when calcifications are involved, that risk is individualized based on sampling adequacy.
Next Steps in Your Care
Because papillomatosis involves multiple areas, your doctors will focus on radiology-pathology concordance [2]. This is a fancy way of saying they want to make sure the biopsy results explain exactly what they saw on your mammogram or ultrasound.
- Active Surveillance: If the results are benign, adequately sampled, and match the imaging perfectly, your doctor may suggest monitoring the area with imaging rather than surgery [16][17].
- Surgical Excision: If the biopsy was unclear, if there is atypia, or if the growths are causing bothersome symptoms, your doctor might recommend an excision to remove the affected area [18][12].
Your care team will look at your age, your family history, and the specific details of your imaging to help you decide which path is right for you [19][20].
Common questions in this guide
What is intraductal breast papillomatosis?
Does intraductal breast papillomatosis mean I have breast cancer?
How is papillomatosis different from a solitary intraductal papilloma?
What does atypia mean in a breast papilloma pathology report?
Do I need surgery for intraductal breast papillomatosis?
What does radiology-pathology concordance mean?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on intraductal breast papillomatosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my pathology report specifically state my papillomatosis is 'without atypia'?
- 2.How many papillomas were seen on my imaging, and what are their sizes?
- 3.Was my biopsy result formally reviewed as 'concordant' with what you saw on the imaging?
- 4.Based on my results and family history, do you recommend surgical excision or active surveillance?
- 5.If we choose surveillance, what is the follow-up schedule and imaging type for monitoring?
References
References (20)
- 1
Multiple Papillomas of the Breast: A Review of Current Evidence and Challenges.
Rella R, Romanucci G, Arciuolo D, et al.
Journal of imaging 2022; (8(7)) doi:10.3390/jimaging8070198.
PMID: 35877642 - 2
Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation.
Thai JN, Vickery J, Boyraz B, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(8)):e240091 doi:10.1148/rg.240091.
PMID: 40674246 - 3
Ductal carcinoma in situ of the breast arising in a solitary intraductal papilloma.
Badrawi N, AlSayegh AA
Radiology case reports 2023; (18(2)):449-451 doi:10.1016/j.radcr.2022.11.014.
PMID: 36439917 - 4
Papillary neoplasms of the breast-reviewing the spectrum.
Tay TKY, Tan PH
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021; (34(6)):1044-1061 doi:10.1038/s41379-020-00732-3.
PMID: 33462367 - 5
Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast.
Hashmi AA, Faraz M, Rafique S, et al.
Cureus 2020; (12(10)):e11026 doi:10.7759/cureus.11026.
PMID: 33214954 - 6
Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components.
Mishima C, Kagara N, Ikeda JI, et al.
The American journal of pathology 2018; (188(5)):1106-1112 doi:10.1016/j.ajpath.2018.01.005.
PMID: 29454754 - 7
Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB, Tse GM
Histopathology 2016; (68(1)):22-32 doi:10.1111/his.12866.
PMID: 26768027 - 8
Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Annals of diagnostic pathology 2020; (49()):151605 doi:10.1016/j.anndiagpath.2020.151605.
PMID: 32920473 - 9
Papillomas of the breast: factors associated with underestimation.
Boufelli G, Giannotti MA, Ruiz CA, et al.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(4)):310-314 doi:10.1097/CEJ.0000000000000343.
PMID: 28296665 - 10
Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N, Cevik J, Hopkins D, Lippey J
Journal of surgical oncology 2024; (129(6)):1025-1033 doi:10.1002/jso.27592.
PMID: 38305061 - 11
Papillary lesions of the breast - review and practical issues.
Ni Y, Tse GM
Seminars in diagnostic pathology 2022; (39(5)):344-354 doi:10.1053/j.semdp.2022.06.001.
PMID: 35718581 - 12
Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X, Liu W, Hai T, Li F
Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.
PMID: 34331160 - 13
Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H, Bomeisl P, Amin AL, et al.
Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.
PMID: 35863513 - 14
Differential Diagnosis of Benign and Malignant Breast Papillary Neoplasms on MRI With Non-mass Enhancement.
Zhou J, Li M, Liu D, et al.
Academic radiology 2023; (30 Suppl 2()):S127-S132 doi:10.1016/j.acra.2023.02.010.
PMID: 36906443 - 15
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
Nakhlis F, Baker GM, Pilewskie M, et al.
Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.
PMID: 33047246 - 16
Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.
Limberg J, Kucher W, Fasano G, et al.
Annals of surgical oncology 2021; (28(11)):6032-6040 doi:10.1245/s10434-021-09870-7.
PMID: 33876349 - 17
High-Risk Breast Lesions on Core Biopsy: Rates of Upgrade and Management Recommendations.
Grabenstetter A
Surgical pathology clinics 2025; (18(4)):707-723 doi:10.1016/j.path.2025.05.001.
PMID: 41224414 - 18
Analysis of 612 Benign Papillomas Diagnosed at Core Biopsy: Rate of Upgrade to Malignancy, Factors Associated With Upgrade, and a Proposal for Selective Surgical Excision.
Lee SJ, Wahab RA, Sobel LD, et al.
AJR. American journal of roentgenology 2021; (217(6)):1299-1311 doi:10.2214/AJR.21.25832.
PMID: 34008998 - 19
Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis.
Lou C, Wang W, Zhou B
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2024; (43(3)):39-49 doi:10.1615/JEnvironPatholToxicolOncol.2024052888.
PMID: 38608144 - 20
Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
Abbassi-Rahbar S, Sack S, Larson KE, et al.
Annals of surgical oncology 2021; (28(10)):5768-5774 doi:10.1245/s10434-021-10520-1.
PMID: 34338925
This page explains intraductal breast papillomatosis for educational purposes and does not replace medical advice. Ask your breast-imaging specialist, pathologist, or surgeon to interpret your biopsy and recommend follow-up.